Real-world clinical multi-omics analyses reveal bifurcation of ER-independent and ER-dependent drug resistance to CDK4/6 inhibitors Autor Zhengyan Kan, Ji Wen, Vinicius Bonato, Jennifer Webster, Wenjing Yang, Vladimir Ivanov, Kimberly Hyunjung Kim, Whijae Roh, Chaoting Liu, Xinmeng Jasmine Mu, Jennifer Lapira-Miller, Jon Oyer, Todd VanArsdale, Paul A. Rejto, Jadwiga Bienkowska

Získat plný text

PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib Autor Xia Ding, Zhou Zhu, John Lapek, Elizabeth A. McMillan, Alexander Zhang, Chi-Yeh Chung, Sara Dubbury, Jennifer Lapira, Sarah Firdaus, Xiaolin Kang, Jingjin Gao, Jon Oyer, John Chionis, Robert A. Rollins, Lianjie Li, Sherry Niessen, Shubha Bagrodia, Lianglin Zhang, Todd VanArsdale

Získat plný text

737 Inhibition of P21-activated kinase 4 (PAK4) reverts immune exclusion and restores anti-tumor immunity in the tumor microenvironment Autor Rajarshi Bhadra, Keith Ching, Johnni Gullo-Brown, Jonathan Heyen, Yu 'Jerry' Zhou, Gina Chu, Eleanore Hendrickson, Brandy Chavez, Indrawan McAlpine, Eugene Rui, Shawn Doran, Sergei Timofeevski, Jennifer Kinong, Szu-Yu Tang, Jon Oyer, Vinayak Rayannavar, Andrew Nager, Stephanie Shi, Christopher Dillon, Murali Gururajan